1. Home
  2. RVTY

as of 02-13-2026 3:46pm EST

$95.74
+$0.17
+0.18%
Stocks Industrials Biotechnology: Laboratory Analytical Instruments Nasdaq

Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.

Founded: 1937 Country:
United States
United States
Employees: N/A City: WALTHAM
Market Cap: 11.8B IPO Year: N/A
Target Price: $113.00 AVG Volume (30 days): 1.7M
Analyst Decision: Buy Number of Analysts: 15
Dividend Yield:
0.29%
Dividend Payout Frequency: Quarterly
EPS: 2.07 EPS Growth: -5.83
52 Week Low/High: $81.36 - $120.39 Next Earning Date: 02-02-2026
Revenue: $2,856,051,000 Revenue Growth: 3.67%
Revenue Growth (this year): 6.06% Revenue Growth (next year): 5.15%
P/E Ratio: 46.20 Index:
Free Cash Flow: 509.4M FCF Growth: -5.95%

AI-Powered RVTY Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold
Model Accuracy: 72.32%
72.32%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of Revvity Inc. (RVTY)

Goldberg Joel S

Please See Remarks

Sell
RVTY Feb 5, 2026

Avg Cost/Share

$100.96

Shares

12,717

Total Value

$1,274,356.53

Owned After

43,247

SEC Form 4

Singh Prahlad R.

Please See Remarks

Sell
RVTY Feb 5, 2026

Avg Cost/Share

$100.63

Shares

25,525

Total Value

$2,557,858.90

Owned After

121,281

Vohra Tajinder S

Please See Remarks

Sell
RVTY Feb 2, 2026

Avg Cost/Share

$104.50

Shares

5,756

Total Value

$601,502.00

Owned After

10,442

SEC Form 4

Share on Social Networks: